These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34346586)

  • 1. [Proton therapy and the importance of RCT].
    Verkooijen HM
    Ned Tijdschr Geneeskd; 2021 Jul; 165():. PubMed ID: 34346586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Should every innovation be evaluated in an RCT? Considerations for the selection of patients for proton therapy].
    De Ruysscher D; Boersma LJ
    Ned Tijdschr Geneeskd; 2021 Jul; 165():. PubMed ID: 34346662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO).
    Hurkmans CW; Knegjens JL; Oei BS; Maas AJ; Uiterwaal GJ; van der Borden AJ; Ploegmakers MM; van Erven L;
    Radiat Oncol; 2012 Nov; 7():198. PubMed ID: 23176563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology.
    Verkooijen HM; Kerkmeijer LGW; Fuller CD; Huddart R; Faivre-Finn C; Verheij M; Mook S; Sahgal A; Hall E; Schultz C
    Front Oncol; 2017; 7():59. PubMed ID: 28421162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical controversies: proton therapy for prostate cancer.
    Mouw KW; Trofimov A; Zietman AL; Efstathiou JA
    Semin Radiat Oncol; 2013 Apr; 23(2):109-14. PubMed ID: 23473687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of MR-linac and proton therapy in two radiotherapy departments in The Netherlands: Recommendations based on lessons learned.
    Jacobs M; Kerkmeijer L; de Ruysscher D; Brunenberg E; Boersma L; Verheij M
    Radiother Oncol; 2022 Feb; 167():14-24. PubMed ID: 34915064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine.
    Widder J; van der Schaaf A; Lambin P; Marijnen CAM; Pignol JP; Rasch CR; Slotman BJ; Verheij M; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):30-36. PubMed ID: 26684410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives.
    Hua CH; Mascia AE; Seravalli E; Lomax AJ; Seiersen K; Ulin K
    Pediatr Blood Cancer; 2021 May; 68 Suppl 2(Suppl 2):e28344. PubMed ID: 33818892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging (MRI) guided proton therapy: A review of the clinical challenges, potential benefits and pathway to implementation.
    Pham TT; Whelan B; Oborn BM; Delaney GP; Vinod S; Brighi C; Barton M; Keall P
    Radiother Oncol; 2022 May; 170():37-47. PubMed ID: 35257848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How rapid advances in imaging are defining the future of precision radiation oncology.
    Beaton L; Bandula S; Gaze MN; Sharma RA
    Br J Cancer; 2019 Apr; 120(8):779-790. PubMed ID: 30911090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in clinical trials in proton radiotherapy: the present and the future.
    Miller RC; Lodge M; Murad MH; Jones B
    Semin Radiat Oncol; 2013 Apr; 23(2):127-33. PubMed ID: 23473690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical controversies: proton radiation therapy for brain and skull base tumors.
    Combs SE; Laperriere N; Brada M
    Semin Radiat Oncol; 2013 Apr; 23(2):120-6. PubMed ID: 23473689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Innovation in radiotherapy in 2021].
    Masson I; Dutreix M; Supiot S
    Bull Cancer; 2021 Jan; 108(1):42-49. PubMed ID: 33303195
    [No Abstract]   [Full Text] [Related]  

  • 15. Physics controversies in proton therapy.
    Engelsman M; Schwarz M; Dong L
    Semin Radiat Oncol; 2013 Apr; 23(2):88-96. PubMed ID: 23473685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.
    Beenakker JM; Rasch CRN
    Radiother Oncol; 2022 Nov; 176():251. PubMed ID: 35988772
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to "Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.".
    Via R; Fattori G; Pica A; Paganelli C; Lomax A; Schalenbourg A; Weber DC; Baroni G; Hrbacek J
    Radiother Oncol; 2022 Nov; 176():252. PubMed ID: 35988774
    [No Abstract]   [Full Text] [Related]  

  • 18. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP; Eich HT
    Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck proton therapy in France: A missed opportunity or a challenge in front of us?
    Thariat J; Calugaru V; Aloi D; Maingon P; Grégoire V
    Cancer Radiother; 2021 Oct; 25(6-7):537-544. PubMed ID: 34272183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies.
    Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L
    Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.